These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11865972)

  • 21. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardioprotective effect of mexiletine in acute myocardial ischemia tudies in the rabbit closed chest ischemia mode.
    Inuo K; Niwano S; Morohoshi Y; Nakayama S; Ikeda K; Kojima J; Saito J; Masuda T; Izumi T
    Circ J; 2002 Apr; 66(4):403-10. PubMed ID: 11954958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of oral combination therapy with mexiletine and quinidine on left and right ventricular function.
    Sheldon RS; Duff HJ; Mitchell LB; Wyse DG; Manyari DE
    Am Heart J; 1988 May; 115(5):1030-6. PubMed ID: 3284310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular arrhythmias.
    Nademanee K; Feld G; Hendrickson J; Intarachot V; Yale C; Heng MK; Singh BN
    Am Heart J; 1985 Nov; 110(5):923-31. PubMed ID: 3904380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
    Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
    Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Column-switching HPLC determination of mexiletine using tris(bipyridine)ruthenium(III) electrogenerated chemiluminescence and precolumn derivatization with divinylsulfone.
    Kobayashi N; Miyamoto A; Uchikura K
    Anal Sci; 2010; 26(12):1289-94. PubMed ID: 21157099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine.
    Labbé L; Abolfathi Z; Robitaille NM; St-Maurice F; Gilbert M; Turgeon J
    Ther Drug Monit; 1999 Apr; 21(2):191-9. PubMed ID: 10217339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy with investigational antiarrhythmic drugs.
    Mead RH; Harrison DC
    Med Clin North Am; 1984 Sep; 68(5):1321-37. PubMed ID: 6436596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fluvoxamine on the pharmacokinetics of mexiletine in healthy Japanese men.
    Kusumoto M; Ueno K; Oda A; Takeda K; Mashimo K; Takaya K; Fujimura Y; Nishihori T; Tanaka K
    Clin Pharmacol Ther; 2001 Mar; 69(3):104-7. PubMed ID: 11240973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New antiarrhythmic drugs.
    Troup PJ; Zipes DP
    Compr Ther; 1978 Nov; 4(11):43-8. PubMed ID: 720024
    [No Abstract]   [Full Text] [Related]  

  • 35. Concentration response relationships of amiodarone and desethylamiodarone.
    Connolly SJ; Gupta RN; Hoffert D; Roberts RS
    Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration.
    Kotake T; Takada M; Goto T; Komamura K; Kamakura S; Morishita H
    J Clin Pharm Ther; 2006 Jun; 31(3):237-43. PubMed ID: 16789989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination anti-arrhythmic drug therapy].
    Lüderitz B; Jung W; Manz M
    Z Kardiol; 1992; 81 Suppl 4():157-61. PubMed ID: 1283933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
    Haedo AH; Chiale PA; Bandieri JD; Lázzari JO; Elizari MV; Rosenbaum MB
    J Am Coll Cardiol; 1986 May; 7(5):1114-20. PubMed ID: 3958370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.